Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Durham NC, Fairfax VA, Baltimore MD, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase 2, Recruiting
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase 1, Phase 2, Recruiting
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma, Cancer
Location: Durham NC, Chapel Hill NC, Charlotte NC, Wilmington NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05145400
Phase 2, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Fairfax VA, Pittsburgh PA, Philadelphia PA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase 1, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Durham NC, Norfolk VA, Annapolis MD, Philadelphia PA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
for
Low Risk Myelodysplastic Syndromes
Location: Durham NC, Columbus OH, Cleveland OH, New York NY,
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05308264
Phase 1, Phase 2, Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Location: Durham NC, New York NY, Nashville TN, Providence RI,
Sponsor: Context Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06515613
Phase 1, Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Durham NC, Fairfax VA, Philadelphia PA, Nashville TN,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06108050
Phase 1, Recruiting
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
for
Prostate Cancer,
Location: Durham NC, Charlottesville VA, Myrtle Beach SC,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT04729114
Phase 1, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Durham NC, Huntersville NC, Fairfax VA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Durham NC, Washington DC, Baltimore MD, Boston MA,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Durham NC, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 3 - 39
Code: NCT05096481
Phase 2, Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
for
Relapsed/Refractory Acute Myeloid Leukemia (AML),
Location: Durham NC, Atlanta GA, New York NY, Buffalo NY,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05143996
Phase 1, Phase 2, Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Durham NC, Atlanta GA, Toronto, Boston MA, St Louis MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Phase 4, Recruiting
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation
Sex: All
Age: 65+
Code: NCT02802267
Phase 2, Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Durham NC, Raleigh NC, Norfolk VA, Fairfax VA,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05659381
Phase 3, Recruiting
Optimizing Surgical Decisions in Young Adults With Breast Cancer
for
Breast Cancer Stage 0, Breast Cancer Stage I,
Location: Durham NC, New York NY, New Haven CT, Boston MA
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 44
Code: NCT06275126
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy